Universal Health Services... (UHS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 193.1 |
Market Cap | 11.35B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 15.03 |
PE Ratio (ttm) | 12.86 |
Forward PE | n/a |
Analyst | Hold |
Ask | 193.4 |
Volume | 154,621 |
Avg. Volume (20D) | 606,993 |
Open | 194.09 |
Previous Close | 192.64 |
Day's Range | 192.16 - 195.53 |
52-Week Range | 152.69 - 243.25 |
Beta | undefined |
About UHS
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, ...
Analyst Forecast
According to 14 analyst ratings, the average rating for UHS stock is "Hold." The 12-month stock price forecast is $226, which is an increase of 16.95% from the latest price.
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
Why Price Moved
News
1 month ago · https://thefly.com
Tenet Healthcare downgraded to Neutral from Buy at Goldman SachsGoldman Sachs analyst Jamie Perse downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. Amid rising policy uncertainty, with a wide range of potential outcomes, ...
1 month ago · https://thefly.com
Universal Health downgraded to Neutral from Buy at Goldman SachsGoldman Sachs downgraded Universal Health to Neutral from Buy with a price target of $198, down from $228. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a ...